An angiotensin-derived peptide studied in synaptogenesis research.
Dihexa is a synthetic peptide derived from angiotensin IV, studied in synaptogenesis and neural-connectivity research models. It is an investigational research compound sold strictly as a research material.
In animal and in-vitro models, researchers have examined this compound's relationship to:
These are areas of laboratory investigation, not established outcomes in people. For primary literature, see PubMed — Dihexa research.
Part of the Neurological category. Related: Semax · Selank · Neurological hub
This compound is sold in the U.S. for research use only and is not approved for human consumption. The peptide compounding landscape shifted in 2026 — read our breakdown: The 2026 FDA Peptide Reclassification, Explained.
We only list vendors we have personally vetted and partnered with. None of our current verified partners stock Dihexa yet — we’re adding new vetted suppliers regularly. In the meantime, browse compounds our trusted vendors do carry.
Products discussed are for laboratory and research purposes only — not for human consumption.
No. Dihexa is an investigational research compound; it is not approved for human consumption and is sold for research use only.
Look for batch-specific, third-party Certificates of Analysis (COAs), transparent purity testing, U.S. sourcing, and a real reputation across independent review platforms. Our vendor reviews check all of these.
No. We're an independent research and comparison resource. We link to vetted third-party vendors and disclose every affiliate relationship.
Last reviewed June 2026. By the Peptides Uncaged Research Team.
Join the list for honest peptide breakdowns and ranking updates. No spam, ever.
Vendor pricing moves constantly, and the sticker price on a vial is not the number that matters — cost per milligram is. Our sister index reads all four vendor storefronts directly and normalises every listing.